Kalorama Information

More than 1 out of every 4 sequencers owned by labs surveyed is still a Sanger or capillary type system, and almost all are made by Life Technologies / Applied Biosystems. And those labs that own them are still employing them at a fairly stable rate.

The market for laboratory information management systems will grow to nearly 1.5 billion-dollars in 2015. Growth will be spurred by the desire of clinical diagnostic laboratories to handle larger amounts of data from molecular testing and sequencing.

The global market for cloud computing in healthcare is estimated to reach $3.9 billion for 2013, representing 21.1% growth over the 2012 year.

Illumina has the most prevalent model of sequencer in a worldwide survey of labs performing sequencing, according to a recent Kalorama Information survey.

Minimally invasive surgeries, such as laparoscopic hernia, endoscopy or knee repair, have grown in popularity. This has boosted the worldwide market for devices used in these procedures, valued at $27 billion in 2012.

On the whole, Patient Protection and Affordable Care Act is expected to benefit the IVD and clinical lab test industry slightly. Sales are likely to rise an extra 1.3% per year more, in the next five years, than it would have without the law.

A relatively new approach to cancer research and diagnosis has developed into a nearly one billion-dollar market according to Kalorama Information.

Innovative point-of-care tests that can assist operators with capturing test results and “reading” for a specific diagnosis are driving revenue growth of the lateral flow test category.

As cancer diagnostics prove to be the key to early detection and improved cancer outcomes, developing nations will be an increasingly important market for these products, says Kalorama Information.

The global market for tablet PC devices in healthcare is expected to increase to $1.7 billion for 2013, reflecting an increase of nearly 27% over the prior year, according to Kalorama Information.